Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            April 15, 2025
            Published by admin on April 15, 2025
            Categories
            • GBC Blog

            Inbiome’s Bacterial Identification System Secures IVDR Certification

            Dutch diagnostics company Inbiome has secured the EU’s In Vitro Diagnostic Regulation (IVDR) certification for its rapid bacterial identification system. This certification allows for the commercial […]
            Do you like it?0
            Read more
            April 10, 2025
            Published by admin on April 10, 2025
            Categories
            • GBC Blog

            Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer’s Disease

            SECAUCUS, N.J., April 9, 2025 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of […]
            Do you like it?0
            Read more
            April 3, 2025
            Published by admin on April 3, 2025
            Categories
            • GBC Blog

            Samantree Histolog Scanner

            https://www.samantree.com/
            Do you like it?0
            Read more
            April 3, 2025
            Published by admin on April 3, 2025
            Categories
            • GBC Blog

            Federal Court Vacates FDA Rule on Laboratory Developed Testing (LDT) Services

            Washington, D.C.— The American Clinical Laboratory Association (ACLA) and its member company, HealthTrackRx, today announced a victory in its legal challenge to the U.S. Food and Drug Administration’s (FDA) Final Rule that […]
            Do you like it?0
            Read more
            March 27, 2025
            Published by admin on March 27, 2025
            Categories
            • GBC Blog

            Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

            BERKELEY, US – MAINZ, Germany – March 27, 2025 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the […]
            Do you like it?0
            Read more
            March 11, 2025
            Published by admin on March 11, 2025
            Categories
            • GBC Blog

            Guardant Health’s Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic Status

            NEW YORK – Guardant Health announced Tuesday that its Shield blood test for colorectal cancer screening has received Advanced Diagnostic Laboratory Test (ADLT) status from the […]
            Do you like it?0
            Read more
            January 30, 2025
            Published by admin on January 30, 2025
            Categories
            • GBC Blog

            Food and Drug Administration Announces the Availability of New Draft Guidance for Industry: “E6(R3) Guideline for Good Clinical Practic.”

            The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “E6(R3) Guideline for Good Clinical Practice.”  The […]
            Do you like it?0
            Read more
            January 22, 2025
            Published by admin on January 22, 2025
            Categories
            • GBC Blog

            January is Cervical Cancer Awareness Month

            JOIN WITH THE AACR TO FIND BETTER WAYS TO PREVENT AND TREAT CERVICAL CANCER
            Do you like it?0
            Read more
            September 4, 2024
            Published by admin on September 4, 2024
            Categories
            • GBC Blog

            Biotech firm Recursion to Buy Smaller Peer Exscientia

            NEW YORK, Aug 8 (Reuters) – Recursion Pharmaceuticals (RXRX.O), opens new tab, a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to […]
            Do you like it?0
            Read more
            123456789101112131415161718192021
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕